Fecal occult blood testing in a general medical clinic: Comparison between guaiac-based and immunochemical-based tests

American Journal of Medicine

Volumn 115, Issue 2, 2003, Pages 111-114

  Ko, Cynthia W ^a,b   Dominitz, Jason A ^a   Nguyen, Toan D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEMATOCHEZIA; HUMAN; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OCCULT BLOOD; OCCULT BLOOD TEST; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; COLONOSCOPY; COLORECTAL TUMOR; COMPARATIVE STUDY; EVALUATION; FEMALE; GENERAL PRACTICE; GOVERNMENT; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; OUTPATIENT DEPARTMENT; PATIENT REFERRAL; PREDICTION AND FORECASTING; STATISTICS; UNITED STATES; VETERAN;

DIAGNOSTIC AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; GUAIAC;

AGED; AMBULATORY CARE FACILITIES; COLONOSCOPY; COLORECTAL NEOPLASMS; FAMILY PRACTICE; FEMALE; GUAIAC; HUMANS; IMMUNOCHEMISTRY; INDICATORS AND REAGENTS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; REFERRAL AND CONSULTATION; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 0042236609     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(03)00294-8     Document Type: Article

References (22)

1. Winawer S., Fletcher R., Rex D., et al. Colorectal cancer screening and surveillance clinical guidelines and rationale - update based on new evidence . Gastroenterology. 124:2003;544-560.
2. Byers T., Levin B., Rothenberg D., et al. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer update 1997 . CA Cancer J Clin. 47:1997;154-160.
3. Rex D.K., Johnson D.A., Lieberman D.A., et al. Colorectal cancer prevention 2000 screening recommendations of the American College of Gastroenterology. American College of Gastroenterology . Am J Gastroenterol. 95:2000;868-877.
4. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002;137:129-131.
5. Mandel J.S., Bond J.H., Church T.R., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 328:1993;1365-1371.
6. Hardcastle J.D., Chamberlain J.O., Robinson M.H.E., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 348:1996;1472-1477.
7. Kronborg O., Fenger C., Olsen J., et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 348:1996;1467-1471.
8. Ransohoff D.F., Lang C.A. Screening for colorectal cancer with the fecal occult blood test a background paper. American College of Physicians . Ann Intern Med. 126:1997;811-822.
9. Greenberg P.D., Bertario L., Gnauck R., et al. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol. 95:2000;1331-1338.
10. Rozen P., Knaani J., Samuel Z. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia. Dig Dis Sci. 42:1997;2064-2071.
11. Levin B., Hess K., Johnson C. Screening for colorectal cancer a comparison of 3 fecal occult blood tests . Arch Intern Med. 157:1997;970-976.
12. Allison J.E., Tekawa I.S., Ransom L.J., Adrain A.L. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med. 334:1996;155-159.
13. Rozen P., Knaani J., Samuel Z. Comparative screening with a sensitive guaiac and specific immunochemical occult blood test in an endoscopic study. Cancer. 89:2000;46-52.
14. Faivre J., Arveux P., Milan C., et al. Participation in mass screening for colorectal cancer results of screening and rescreening from the Burgundy study . Eur J Cancer Prev. 1:1991;49-55.
15. Morris J.B., Stellato T.A., Guy B.B., et al. A critical analysis of the largest reported mass fecal occult blood screening program in the United States. Am J Surg. 161:1991;101-105.
16. Morrow G.R., Way J., Hoagland A.C., Cooper R. Patient compliance with self-directed hemoccult testing. Prev Med. 11:1982;512-520.
17. Thompson N.J., Boyko E.J., Dominitz J.A., et al. A randomized controlled trial of a clinic-based support staff intervention to increase the rate of fecal occult blood test ordering. Prev Med. 30:2000;244-251.
18. Lieberman D.A., Weiss D.G. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 345:2001;555-560.
19. Imperiale T.F., Wagner D.R., Lin C.Y., et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 343:2000;169-174.
20. Myers R.E., Balshem A.M., Wolf T.A., et al. Screening for colorectal neoplasia physicians' adherence to complete diagnostic evaluation . Am J Public Health. 83:1993;1620-1622.
21. Lurie J., Welch H. Diagnostic testing following fecal occult blood screening in the elderly. J Natl Cancer Inst. 91:1999;1641-1646.
22. Winawer S.J., Stewart E.T., Zauber A.G., et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. N Engl J Med. 342:2000;1766-1772.